Delivery Order SPE2DB22D2211-SPE2DB25FSDPH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,119.24 to AmerisourceBergen Drug Corp for Belsomra 15 mg tablets (30-count supply) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Belsomra 20 mg tablets (30-count packaging) valued at $1,305.88. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set to be completed by September 4, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. Belsomra (suvorexant) is a prescription sleep...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,101.78 to AmerisourceBergen Drug Corp for the supply of Belsomra 10 mg tablets (30-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation reflects a routine pharmaceutical supply transaction supporting federal medical procurement needs. The place of performance is listed as Conshohocken, Pennsylvania, which serves...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Belsomra 10mg tablets (30-count) under a firm fixed-price contract valued at $1,072.12. This competitively awarded, non-set-aside delivery order is set to complete by September 3, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,290.81 delivery order is for the supply of Belsomra 20 mg tablets, a prescription sleep medication. The contract is a firm-fixed price arrangement with an ultimate completion date of October 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order contract award from the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Belsomra 20 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with a ceiling value of $1,181.89 and an ultimate completion date of July 23, 2025. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen's...
- This federal contract award, valued at $1,058.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the prescription medication Belsomra 10 mg tablets, with a performance period through April 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,124.80 firm-fixed-price contract is for the delivery of BELSOMRA 5 MG TABLET 30S, with a period of performance through July 11, 2025. The award is not set-aside and represents an open competition. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at one hundred twenty-seven dollars and thirty-two cents ($127.32) to Amerisourcebergen Drug Corporation for twenty (20) 20mg tablets of Belsomra. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility from August 4th through August 7th, 2023. As the prime contractor, Amerisourcebergen will fulfill this order for the sleep aid medication in support of the Defense Logistics Agency's...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BELSOMRA 20 MG TABLET 30S, a pharmaceutical product. The $1,000.49 contract has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDPHDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,427.58 to AmerisourceBergen Drug Corp for Belsomra 10 mg tablets (30-count) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price contract was awarded competitively with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Belsomra is a prescription medication used for sleep disorders, reflecting the pharmaceutical supplier's role in supporting military and federal healthcare systems. This delivery order is a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The company's consistent receipt of competitive, non-set-aside delivery orders across its federal portfolio demonstrates its capability to meet federal procurement requirements for pharmaceutical products and medical supplies serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/25/25 |